'No Time to Die' debuts slightly behind expectations with $56 million | Inquirer Entertainment
Close  

‘No Time to Die’ debuts slightly behind expectations with $56 million

/ 06:39 AM October 11, 2021
The World Premiere of "No Time To Die" in London

Cast member Daniel Craig poses during the world premiere of the new James Bond film “No Time To Die” at the Royal Albert Hall in London, Britain, Sept. 28, 2021. Image: Reuters/Toby Melville

LOS ANGELES — “No Time to Die,” the latest installment in the James Bond franchise, debuted to $56 million at the domestic box office, a result that fell somewhat short of expectations and signals that even one of the most storied brands in film history is still being forced to contend with a moviegoing landscape that has been dramatically altered by the pandemic.

Heading into the weekend, “No Time to Die” was projected to make $60 million to $70 million in its first three days of release. Though not a disaster, the film’s final weekend total was expected to be higher because it received positive reviews and represented Daniel Craig’s final outing as the stylish secret agent.

ADVERTISEMENT

In light of the ongoing pandemic, assessing initial box office results for “No Time to Die” isn’t as clear cut. For some movies, especially during a public health crisis, an opening weekend of $56 million would be cause for great jubilation.

But “No Time to Die” is no ordinary film. It carries a massive $250 million production budget, to say nothing of the more than $100 million marketing spend.

FEATURED STORIES

Add in the tens of millions it cost to delay “No Time to Die,” which was supposed to premiere in April of 2020 before the pandemic altered those plans, and box office experts estimate that, conservatively, “No Time to Die” needs to gross at least $800 million at the global box office to make money in its theatrical window.

For Bond, the franchise has numerous marketing partners and ancillary tie-ins, with Rolex, Aston Martin and more, that could help cushion potential losses.

Overseas, audiences have been turning out for “No Time to Die” at the international box office, where it has already made an impressive $145 million.

Directed by Cary Joji Fukunaga (“True Detective”), the 007 adventure has opened in most major markets except for China (set for Oct. 29), which is a popular territory for all things Bond. Globally, the film has collected $313 million.

At the domestic box office, the slightly muted results for “No Time to Die” are attributable to several factors, including hesitation among older audiences to return to the movies and its lengthy two-hour-and-45-minute runtime, which limited the number of screenings per day.

It’s also the first Hollywood tentpole with real competition at the box office. Sony’s comic book sequel “Venom: Let There Be Carnage” opened last weekend and has continued to pull in crowds, which may have cannibalized ticket sales for Bond.

With “No Time to Die” claiming the no. 1 spot on domestic box office charts, the “Venom” follow-up slid to second place with $32 million, a figure that’s more than many pandemic-era releases have made in their entire theatrical run. In total, “Venom: Let There Be Carnage” has generated a mighty $141 million in North America and $185 million worldwide.

ADVERTISEMENT

Since Bond is a property that tends to skew toward older audiences, a demographic that doesn’t always make an effort to watch a film on its opening weekend, box office analysts have been encouraged by “No Time to Die.” According to United Artists Releasing, the company distributing the film in the United States, 25% of ticket buyers returned to theaters for the first time in more than 18 months for Bond.

Among opening weekend crowds, 57% were over the age of 35 and 64% were male. It has an “A-” CinemaScore, a positive sign for the movie’s long-term prospects.

“The audience is broad, with all age groups and segments well-represented, including the 35+ crowd, who have been slow to return to the movies,” says David A. Gross, who runs the movie consulting firm Franchise Entertainment Research. “If anything kept the film from over-performing this weekend, it is the younger groups, who are less committed to the series.”

In a distant third place on domestic charts, “The Addams Family 2” generated $10 million, bringing its North American total to $31.1 million. The animated family comedy, from MGM and United Artists Releasing, is being offered simultaneously on premium video-on-demand platforms.

Disney’s superhero adventure “Shang-Chi and the Legend of the Ten Rings” landed at no. 4 with $4.2 million in its sixth weekend in theaters. Globally, the Marvel comic book adaptation has surpassed $400 million worldwide, making it the sixth-highest grossing film of the year. With $212 million in North America, it remains the highest earning movie of 2021 at the domestic box office.

“The Many Saints of Newark,” a prequel to “The Sopranos,” rounded out the top five with a paltry $1.4 million in its sophomore outing. That puts ticket sales for the Warner Bros. movie, which premiered day-and-date on HBO Max, at a dismal $7.4 million. It cost $50 million to make. GSG/JB

RELATED STORIES:

Daniel Craig bids farewell to James Bond: ‘Massively grateful’

Who will be the next James Bond?

The hottest entertainment news straight to your inbox

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.
Read Next
Don't miss out on the latest news and information.

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: box office, Daniel Craig, James Bond, Movies, No Time to Die
For feedback, complaints, or inquiries, contact us.

Subscribe to our entertainment news

By providing an email address. I agree to the Terms of Use and
acknowledge that I have read the Privacy Policy.



© Copyright 1997-2021 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.